BeiGene, Ltd. (BGNE)
USD 184.71
(0.49%)
USD 184.71
(0.49%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.28 Billion USD | 150.48% |
| 2022 | 1.27 Billion USD | 29.04% |
| 2021 | 990.87 Million USD | 64.86% |
| 2020 | 601.02 Million USD | 54.28% |
| 2019 | 389.57 Million USD | 98.48% |
| 2018 | 196.27 Million USD | 212.29% |
| 2017 | 62.85 Million USD | 212.74% |
| 2016 | 20.09 Million USD | 174.89% |
| 2015 | 7.31 Million USD | 5.5% |
| 2014 | 6.93 Million USD | 120.49% |
| 2013 | 3.14 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 888.06 Million USD | -0.18% |
| 2024 Q2 | 874.44 Million USD | 1.14% |
| 2023 Q3 | 817.68 Million USD | 106.89% |
| 2023 Q4 | 889.67 Million USD | 8.8% |
| 2023 FY | 3.2 Billion USD | 150.48% |
| 2023 Q1 | 328.68 Million USD | -0.15% |
| 2023 Q2 | 395.22 Million USD | 20.24% |
| 2022 FY | 1.27 Billion USD | 29.04% |
| 2022 Q2 | 709.79 Million USD | 140.8% |
| 2022 Q1 | 294.76 Million USD | -3.89% |
| 2022 Q4 | 329.17 Million USD | 1.89% |
| 2022 Q3 | 323.07 Million USD | -54.48% |
| 2021 Q3 | 269.41 Million USD | 15.89% |
| 2021 Q4 | 306.68 Million USD | 13.83% |
| 2021 FY | 990.87 Million USD | 64.86% |
| 2021 Q1 | 182.29 Million USD | -12.53% |
| 2021 Q2 | 232.47 Million USD | 27.53% |
| 2020 Q3 | 161.02 Million USD | 29.61% |
| 2020 Q4 | 208.39 Million USD | 29.42% |
| 2020 FY | 601.02 Million USD | 54.28% |
| 2020 Q2 | 124.23 Million USD | 15.72% |
| 2020 Q1 | 107.36 Million USD | -25.28% |
| 2019 FY | 389.57 Million USD | 98.48% |
| 2019 Q4 | 143.68 Million USD | 36.41% |
| 2019 Q1 | 57.97 Million USD | -20.39% |
| 2019 Q2 | 82.58 Million USD | 42.44% |
| 2019 Q3 | 105.33 Million USD | 27.55% |
| 2018 Q2 | 45.34 Million USD | 55.82% |
| 2018 Q1 | 29.1 Million USD | 5.44% |
| 2018 FY | 196.27 Million USD | 212.29% |
| 2018 Q4 | 72.82 Million USD | 48.59% |
| 2018 Q3 | 49 Million USD | 8.07% |
| 2017 FY | 62.85 Million USD | 212.74% |
| 2017 Q2 | 10.77 Million USD | 22.9% |
| 2017 Q3 | 15.7 Million USD | 45.72% |
| 2017 Q4 | 27.6 Million USD | 75.76% |
| 2017 Q1 | 8.76 Million USD | 5.18% |
| 2016 Q1 | 3.13 Million USD | 6.24% |
| 2016 Q4 | 8.33 Million USD | 76.56% |
| 2016 Q3 | 4.72 Million USD | 20.95% |
| 2016 Q2 | 3.9 Million USD | 24.57% |
| 2016 FY | 20.09 Million USD | 174.89% |
| 2015 FY | 7.31 Million USD | 5.5% |
| 2015 Q2 | 1.2 Million USD | 6.71% |
| 2015 Q1 | 1.13 Million USD | -30.38% |
| 2015 Q3 | 2.02 Million USD | 67.3% |
| 2015 Q4 | 2.95 Million USD | 45.97% |
| 2014 Q3 | 3.8 Million USD | 540.07% |
| 2014 Q4 | 1.62 Million USD | -57.23% |
| 2014 FY | 6.93 Million USD | 120.49% |
| 2014 Q1 | 594 Thousand USD | 0.0% |
| 2014 Q2 | 594 Thousand USD | 0.0% |
| 2013 FY | 3.14 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbCellera Biologics Inc. | 275.23 Million USD | -1094.118% |
| Alkermes plc | 996.24 Million USD | -229.898% |
| Agenus Inc. | 78.18 Million USD | -4103.721% |
| Aptorum Group Limited | 10.56 Thousand USD | -31105285.198% |
| Ardelyx, Inc. | 169.93 Million USD | -1834.008% |
| Dyadic International, Inc. | 9.15 Million USD | -35808.491% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -14669.222% |
| Lantern Pharma Inc. | 17.87 Million USD | -18283.902% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -48720.89% |
| Novavax, Inc. | 779.12 Million USD | -321.832% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -3954.421% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -3898.485% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -16825.058% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -11001.111% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -6086.371% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -763.766% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -13421.405% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -8578.853% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -10580.82% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -3779.545% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -18726.803% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -1851.243% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -9946.141% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -1956.86% |
| Alnylam Pharmaceuticals, Inc. | 1.8 Billion USD | -82.582% |
| AlloVir, Inc. | 180.93 Million USD | -1716.471% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -637.34% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -10972.687% |
| Bicycle Therapeutics plc | 216.92 Million USD | -1415.105% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -1811.9% |
| ChromaDex Corporation | 56.37 Million USD | -5729.467% |
| Chimerix, Inc. | 93.38 Million USD | -3419.253% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -23528.18% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -2083.262% |
| CRISPR Therapeutics AG | 463.49 Million USD | -609.091% |
| Precision BioSciences, Inc. | 92.46 Million USD | -3454.497% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -1193.711% |
| Fortress Biotech, Inc. | 200.19 Million USD | -1541.697% |
| Fortress Biotech, Inc. | 200.19 Million USD | -1541.697% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -9936.63% |
| ImmuCell Corporation | 9.61 Million USD | -34073.56% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -1982.575% |
| Immix Biopharma, Inc. | 16.14 Million USD | -20261.638% |
| Incyte Corporation | 1.19 Billion USD | -176.07% |
| Innoviva, Inc. | 132.15 Million USD | -2386.943% |
| IO Biotech, Inc. | 91.44 Million USD | -3494.146% |
| Jaguar Health, Inc. | 42.01 Million USD | -7722.432% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -1841.548% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -3797.626% |
| ContextLogic Inc. | 387 Million USD | -749.249% |
| MiMedx Group, Inc. | 229.72 Million USD | -1330.652% |
| MEI Pharma, Inc. | 34.78 Million USD | -9348.311% |
| NextCure, Inc. | 67.63 Million USD | -4759.167% |
| Onconetix, Inc. | 34.9 Million USD | -9315.173% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -25685.305% |
| Opthea Limited | 191.96 Million USD | -1612.059% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -119343.702% |
| Vaxcyte, Inc. | 468.04 Million USD | -602.202% |
| PDS Biotechnology Corporation | 43.04 Million USD | -7535.212% |
| Precigen, Inc. | 84.18 Million USD | -3804.2% |
| Pharming Group N.V. | 225.49 Million USD | -1357.528% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -1858.323% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -4429.111% |
| PureTech Health plc | 144.59 Million USD | -2172.934% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -2423.046% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -1240.603% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -13421.405% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -1337.203% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -10550.361% |
| Acelyrin, Inc. | 422.06 Million USD | -678.696% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -25489236.125% |
| Summit Therapeutics Inc. | 87.68 Million USD | -3648.141% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -8767.351% |
| Senti Biosciences, Inc. | 94.7 Million USD | -3370.35% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -2560.069% |
| Elevation Oncology, Inc. | 45.44 Million USD | -7132.028% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -11052.72% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -83272.78% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -2386.548% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -9542.35% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -38790.013% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -1712.784% |
| Seer, Inc. | 110.49 Million USD | -2874.563% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -4555.629% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -3415.902% |
| ESSA Pharma Inc. | 32.13 Million USD | -10127.747% |
| GlycoMimetics, Inc. | 39.28 Million USD | -8265.968% |
| GT Biopharma, Inc. | 13.57 Million USD | -24108.861% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -1395.062% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -1534.187% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -1166.877% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -5690.439% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -5977.284% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -32972.172% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -714.395% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -17262.75% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -6383.331% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -1165.735% |
| Aptose Biosciences Inc. | 52.35 Million USD | -6177.399% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -22707.146% |
| Soligenix, Inc. | 7.79 Million USD | -42061.503% |
| Century Therapeutics, Inc. | 56.07 Million USD | -5761.488% |
| Kura Oncology, Inc. | 165.8 Million USD | -1882.217% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -2770.213% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -39407.092% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -132336.466% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -2951.677% |
| Autolus Therapeutics plc | 196.72 Million USD | -1570.646% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -3782.248% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -2722.25% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -16856.07% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -921.449% |
| GRI Bio, Inc. | 11.33 Million USD | -28907.899% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -46480.701% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -2405.16% |
| IGM Biosciences, Inc. | 265.59 Million USD | -1137.465% |
| INmune Bio, Inc. | 29.89 Million USD | -10893.427% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -1804.676% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -8052.428% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -20467.75% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -20778.467% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -5192.594% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -2956.672% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -1092.121% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -990.258% |
| Verastem, Inc. | 92.08 Million USD | -3469.127% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -18220.948% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -1669.603% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -2607.089% |
| Histogen Inc. | 14.27 Million USD | -22928.272% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -20379.598% |
| Surrozen, Inc. | 18.55 Million USD | -17617.493% |
| Organovo Holdings, Inc. | 14.91 Million USD | -21935.501% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -64466.653% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -5407.66% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -12714.735% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -6891.863% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -42958.596% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -1744.992% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -6683.764% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -1241.445% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -21287.949% |
| Apollomics, Inc. | 54.14 Million USD | -5970.549% |
| Amarin Corporation plc | 272.35 Million USD | -1106.723% |
| Mesoblast Limited | 5.9 Million USD | -55586.123% |
| Turnstone Biologics Corp. | 78.33 Million USD | -4095.403% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -1246.292% |
| Synaptogenix, Inc. | 8.31 Million USD | -39431.546% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -22432.531% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -1198.762% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -9760.749% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -37115.576% |
| Exelixis, Inc. | 1.58 Billion USD | -107.124% |
| Better Therapeutics, Inc. | 38.26 Million USD | -8489.71% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -1316.331% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -284.306% |
| NLS Pharmaceutics AG | 11.8 Million USD | -27735.839% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -40768.359% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -10857.874% |
| Gritstone bio, Inc. | 148.37 Million USD | -2115.075% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -4672.796% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -19988.944% |
| Avid Bioservices, Inc. | 25.99 Million USD | -12542.695% |
| Insmed Incorporated | 949.26 Million USD | -246.227% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -20847.351% |
| MediWound Ltd. | 18.86 Million USD | -17318.884% |
| OmniAb, Inc. | 83.89 Million USD | -3817.51% |
| Alector, Inc. | 248.8 Million USD | -1220.968% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -1302.682% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -6190.014% |
| Zai Lab Limited | 547.47 Million USD | -500.318% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -724.423% |
| Aura Biosciences, Inc. | 84.99 Million USD | -3766.992% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -1229.862% |
| Immunic, Inc. | 99.22 Million USD | -3212.332% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -1966.885% |
| Veracyte, Inc. | 357.93 Million USD | -818.215% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 63.546% |
| FibroGen, Inc. | 398.11 Million USD | -725.543% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -23028.747% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -47615.161% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -46022.911% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | -0.951% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -12602.798% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -938.278% |
| TG Therapeutics, Inc. | 198.47 Million USD | -1555.924% |
| Galecto, Inc. | 35.62 Million USD | -9125.012% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -7977.355% |
| Fortrea Holdings Inc. | 457.3 Million USD | -618.696% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -5955.114% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -11280.965% |
| XBiotech Inc. | 37.51 Million USD | -8661.917% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -4672.796% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -15816.485% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -2213.51% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -3217.28% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -2868.491% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | -242.98% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -11293.985% |
| Vaxxinity, Inc. | 56.05 Million USD | -5763.58% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -663.189% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -14632.602% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -2864.448% |
| NexImmune, Inc. | 28.16 Million USD | -11568.035% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -59321.911% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -18268.551% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | -16.74% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -12809.364% |
| Scopus BioPharma Inc. | 11.71 Million USD | -27954.883% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -2486.607% |
| Ainos, Inc. | 12.95 Million USD | -25273.894% |
| Pluri Inc. | 22.48 Million USD | -14520.085% |
| Prothena Corporation plc | 282.4 Million USD | -1063.784% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -1543.117% |
| Celularity Inc. | 215.05 Million USD | -1428.237% |
| Rallybio Corporation | 78.93 Million USD | -4063.831% |
| Cue Biopharma, Inc. | 19.54 Million USD | -16718.11% |
| MeiraGTx Holdings plc | 151.07 Million USD | -2075.429% |
| Omeros Corporation | 94.75 Million USD | -3368.665% |
| Humacyte, Inc. | 23.49 Million USD | -13887.296% |
| Immunocore Holdings plc | 308.04 Million USD | -966.938% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -96849.705% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -3683.566% |
| Blueprint Medicines Corporation | 722.86 Million USD | -354.665% |
| CalciMedica, Inc. | 21.81 Million USD | -14964.376% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -4302.083% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -1947.213% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -1818.675% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -1014.327% |
| Pulmatrix, Inc. | 22.03 Million USD | -14813.309% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -9405.698% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -3598.372% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -495.866% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -4430.048% |
| Cytokinetics, Incorporated | 173.61 Million USD | -1793.069% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -9448.781% |
| Nutriband Inc. | 5.73 Million USD | -57217.357% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -7435.815% |
| Vor Biopharma Inc. | 126.03 Million USD | -2507.664% |
| Roivant Sciences Ltd. | 1.18 Billion USD | -176.375% |
| Evogene Ltd. | 27.79 Million USD | -11726.538% |
| ProKidney Corp. | 151.52 Million USD | -2069.055% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -4330.866% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -42626.1% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -435.078% |
| CorMedix Inc. | 48.95 Million USD | -6613.12% |
| BioLineRx Ltd. | 50.8 Million USD | -6369.42% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -2080.886% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -8532.578% |
| Atai Life Sciences N.V. | 125.78 Million USD | -2512.867% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -3925.751% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -3937.14% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -1201.354% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -9938.47% |
| MediciNova, Inc. | 10.9 Million USD | -30051.515% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -2451.308% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -45172.872% |
| GeoVax Labs, Inc. | 6.02 Million USD | -54474.902% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -589.939% |
| Biomea Fusion, Inc. | 126.13 Million USD | -2505.617% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | -150.534% |
| Mereo BioPharma Group plc | 35.84 Million USD | -9069.675% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -1619.929% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -1329.24% |
| Absci Corporation | 73.66 Million USD | -4361.482% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -11815.724% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -2360.21% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -1257.189% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -1154.196% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -1480.139% |
| Allakos Inc. | 196.05 Million USD | -1576.355% |
| Imunon, Inc. | 20.31 Million USD | -16081.813% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -2796.47% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -791.614% |
| BioAtla, Inc. | 129.68 Million USD | -2434.252% |
| NLS Pharmaceutics AG | 11.8 Million USD | -27735.839% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -20644.777% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -3770.316% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -7770.576% |
| XOMA Corporation | 46.46 Million USD | -6973.575% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -2856.342% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -2206.981% |
| aTyr Pharma, Inc. | 12.97 Million USD | -25222.405% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -3070.675% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -1801.195% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -1190.055% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -8685.808% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -39859.505% |
| Akari Therapeutics, Plc | 16.8 Million USD | -19456.081% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -144431.15% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -998.028% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -48744.21% |
| UroGen Pharma Ltd. | 138.88 Million USD | -2266.364% |
| Sutro Biopharma, Inc. | 243 Million USD | -1252.458% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -45078.911% |
| Orgenesis Inc. | 45.75 Million USD | -7082.715% |
| Entera Bio Ltd. | 8.86 Million USD | -36994.752% |
| GH Research PLC | 41.22 Million USD | -7872.915% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -12684.328% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -3857.226% |
| Xencor, Inc. | 306.97 Million USD | -970.632% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -66516.487% |
| Replimune Group, Inc. | 234.77 Million USD | -1299.903% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -15940.083% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -1613.589% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -48744.21% |
| Portage Biotech Inc. | 18.19 Million USD | -17959.207% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -45172.872% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -3031.254% |
| OncoCyte Corporation | 25.63 Million USD | -12719.733% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -53817.436% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -28586.196% |
| Purple Biotech Ltd. | -22.46 Million USD | 14728.544% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -19842.931% |
| scPharmaceuticals Inc. | 65.17 Million USD | -4942.491% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -38782.026% |
| HilleVax, Inc. | 133.34 Million USD | -2364.731% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -31855.226% |
| Tharimmune, Inc. | 9.45 Million USD | -34659.583% |
| Genprex, Inc. | 31.06 Million USD | -10481.246% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -1652.608% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -10374.535% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -429520.261% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -60238.606% |
| OKYO Pharma Limited | 8243.57 USD | -39868488.488% |
| Savara Inc. | 15.74 Million USD | -20773.896% |
| Curis, Inc. | 58.35 Million USD | -5532.071% |
| Daré Bioscience, Inc. | 33.6 Million USD | -9678.796% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -64438.1% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -43950.328% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -12062.664% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -16383.001% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -558.947% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -2038.986% |
| Erasca, Inc. | 141.52 Million USD | -2222.272% |
| bluebird bio, Inc. | 240.23 Million USD | -1268.092% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -72500.262% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | -88.206% |
| DBV Technologies S.A. | 92.16 Million USD | -3466.184% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -72500.262% |
| Moderna, Inc. | 6.39 Billion USD | 48.599% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -7613.382% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -22777.593% |
| Molecular Templates, Inc. | 63.09 Million USD | -5109.293% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -4827.355% |
| Travere Therapeutics, Inc. | 472 Million USD | -596.31% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -2193.331% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -5193.958% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -7470.357% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -1479.107% |
| MacroGenics, Inc. | 217.21 Million USD | -1413.061% |
| RenovoRx, Inc. | 11.39 Million USD | -28739.9% |
| Adicet Bio, Inc. | 152.03 Million USD | -2061.693% |
| Prime Medicine, Inc. | 186.63 Million USD | -1660.937% |
| Aditxt, Inc. | 25.95 Million USD | -12564.733% |
| Adagene Inc. | 41.83 Million USD | -7756.774% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -44859.657% |
| Quantum-Si incorporated | 111.65 Million USD | -2843.421% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -1812.479% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -22445.255% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -9074.795% |
| SciSparc Ltd. | 9.01 Million USD | -36373.144% |
| Vericel Corporation | 142.04 Million USD | -2213.852% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -37866.069% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -14134.713% |
| Generation Bio Co. | 144.46 Million USD | -2174.98% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -3858.322% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -3701.29% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -1011.387% |
| Invivyd, Inc. | 205.75 Million USD | -1497.334% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -4454.657% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -34943.915% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -4267.336% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -31849.013% |
| 2seventy bio, Inc. | 289.88 Million USD | -1033.75% |
| ADMA Biologics, Inc. | 66.58 Million USD | -4835.865% |
| Clene Inc. | 41.07 Million USD | -7901.838% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -25560.714% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -5897.874% |
| GeoVax Labs, Inc. | 6.02 Million USD | -54474.902% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -833.564% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -8847.494% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -9644.411% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -3069.269% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -9984.983% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -1830.135% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -328.098% |
| Evaxion Biotech A/S | 22.27 Million USD | -14657.948% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -2324.744% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -1299.254% |
| Trevena, Inc. | 38.41 Million USD | -8455.945% |
| Surrozen, Inc. | 18.55 Million USD | -17617.493% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -4011.07% |
| Cingulate Inc. | 22.75 Million USD | -14340.739% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 43968.059% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -7257.994% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -39815.212% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -3104.621% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -335.839% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -5194.64% |
| Clearmind Medicine Inc. | 8.74 Million USD | -37498.254% |
| Kronos Bio, Inc. | 128.11 Million USD | -2465.287% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -3809.262% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -111956.318% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -3159.638% |
| Statera Biopharma, Inc. | 28.82 Million USD | -11300.109% |
| ImmunityBio, Inc. | 362.87 Million USD | -805.717% |
| Korro Bio, Inc. | 84.53 Million USD | -3787.897% |
| Kineta, Inc. | 21.15 Million USD | -15435.049% |
| BioVie Inc. | 31.95 Million USD | -10186.615% |
| Codexis, Inc. | 66.51 Million USD | -4840.911% |
| Celularity Inc. | 215.05 Million USD | -1428.237% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -1350.261% |
| Celcuity Inc. | 66.23 Million USD | -4862.371% |
| Virax Biolabs Group Limited | 6.54 Million USD | -50099.532% |
| Cibus, Inc. | 320.3 Million USD | -926.083% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -7543.244% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -9611.012% |
| IN8bio, Inc. | 30.33 Million USD | -10733.619% |
| Kodiak Sciences Inc. | 277.32 Million USD | -1085.123% |
| Annexon, Inc. | 143.72 Million USD | -2186.756% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -2475.883% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -14246.305% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -513430.469% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -321.582% |
| Eyenovia, Inc. | 25.4 Million USD | -12836.067% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -2242.298% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -58990.165% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -4053.255% |
| Arcellx, Inc. | 200.19 Million USD | -1541.664% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -7060.338% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -1418.682% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -32907.884% |
| Moolec Science SA | 52.75 Million USD | -6130.44% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -5275.699% |
| Geron Corporation | 70.44 Million USD | -4565.742% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -6961.872% |
| Royalty Pharma plc | 862.4 Million USD | -281.097% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -3393.702% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -35134.158% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -14424.119% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -1481.523% |
| Humacyte, Inc. | 23.49 Million USD | -13887.296% |
| Structure Therapeutics Inc. | 102.77 Million USD | -3097.855% |
| 89bio, Inc. | 151.2 Million USD | -2073.616% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -4001.476% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -22503.817% |
| Genelux Corporation | 24.33 Million USD | -13405.63% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -9588.397% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -1801.206% |
| Notable Labs, Ltd. | 14.77 Million USD | -22151.828% |
| Liquidia Corporation | 87.98 Million USD | -3635.446% |
| Mustang Bio, Inc. | 48.5 Million USD | -6676.345% |
| Immunovant, Inc. | 282.7 Million USD | -1062.536% |
| Quantum-Si incorporated | 111.65 Million USD | -2843.421% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -14478.58% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -15353.966% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -3121.773% |
| Acasti Pharma Inc. | 11.3 Million USD | -28982.338% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -14238.728% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -20467.75% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -6961.568% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -289575.034% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -20588.625% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -11172.062% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -7841.705% |
| PepGen Inc. | 84.76 Million USD | -3777.256% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -10991.745% |
| United Therapeutics Corporation | 885.1 Million USD | -271.325% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -14253.824% |
| Solid Biosciences Inc. | 104.31 Million USD | -3050.645% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -9942.907% |
| Immuneering Corporation | 58.41 Million USD | -5526.49% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -64466.653% |
| Silo Pharma, Inc. | 3.92 Million USD | -83702.031% |
| Belite Bio, Inc | 31.66 Million USD | -10278.284% |
| XOMA Corporation | 46.46 Million USD | -6973.575% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -4765.426% |
| Bionomics Limited | 17.89 Billion USD | 81.631% |
| Apogee Therapeutics, Inc. | 93 Million USD | -3433.859% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 9311.309% |
| uniQure N.V. | 285.08 Million USD | -1052.843% |
| Cassava Sciences, Inc. | 105.95 Million USD | -3001.82% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -44859.657% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -1592.315% |
| Forte Biosciences, Inc. | 32.47 Million USD | -10019.762% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -39455.806% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -11080.796% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -58990.165% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -23028.747% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -36873.732% |
| Altimmune, Inc. | 30.55 Million USD | -10655.973% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -668.523% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 9311.309% |
| Compugen Ltd. | 43.97 Million USD | -7374.46% |
| Peak Bio, Inc. | 1249.13 USD | -263110625.065% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -4334.154% |
| Benitec Biopharma Inc. | 22.38 Million USD | -14584.099% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -1251.457% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -11414.539% |
| Zura Bio Limited | 62.63 Million USD | -5146.967% |
| PolyPid Ltd. | 21.04 Million USD | -15516.987% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -20092.891% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -11414.539% |
| Instil Bio, Inc. | 85.78 Million USD | -3731.2% |
| argenx SE | 1.53 Billion USD | -114.316% |
| Immunome, Inc. | 122.82 Million USD | -2575.944% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -6680.259% |
| Verona Pharma plc | 67.15 Million USD | -4794.315% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -12596.909% |
| Shattuck Labs, Inc. | 93.61 Million USD | -3410.794% |
| CervoMed Inc. | 14.95 Million USD | -21872.498% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -4548.452% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -38366.702% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -6344.304% |
| Moolec Science SA | 52.75 Million USD | -6130.44% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -19881.196% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -2379.417% |
| AnaptysBio, Inc. | 181.56 Million USD | -1710.118% |
| Design Therapeutics, Inc. | 78.19 Million USD | -4103.344% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -3675.916% |
| NeurAxis, Inc. | 8.82 Million USD | -37157.917% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -26015.177% |
| Lumos Pharma, Inc. | 38.66 Million USD | -8400.181% |
| Achilles Therapeutics plc | 75.25 Million USD | -4267.278% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -12596.909% |
| 180 Life Sciences Corp. | 13.47 Million USD | -24285.791% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -12301.103% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -111956.318% |
| Nutriband Inc. | 5.73 Million USD | -57217.357% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -2866.776% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -5805.513% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -6359.63% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -4872.231% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -5972.445% |
| Palisade Bio, Inc. | 13.32 Million USD | -24574.137% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -7137.761% |
| Beam Therapeutics Inc. | 554.19 Million USD | -493.041% |
| Neurogene Inc. | 55.58 Million USD | -5812.95% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -1222.632% |
| AEON Biopharma, Inc. | 48.42 Million USD | -6686.419% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -3298.402% |
| Sesen Bio, Inc. | 78.38 Million USD | -4093.102% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -3834.675% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -26011.243% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -628.746% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -3639.441% |
| Athira Pharma, Inc. | 125.46 Million USD | -2519.51% |
| Vaccinex, Inc. | 23.45 Million USD | -13912.343% |
| HCW Biologics Inc. | 21.02 Million USD | -15529.97% |
| XOMA Corporation | 46.46 Million USD | -6973.575% |
| Nektar Therapeutics | 190.9 Million USD | -1621.605% |
| Arvinas, Inc. | 480 Million USD | -584.707% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -144431.15% |
| Merus N.V. | 200.49 Million USD | -1539.249% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -3079.909% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -9393.342% |
| Rezolute, Inc. | 70.38 Million USD | -4569.321% |
| Clene Inc. | 41.07 Million USD | -7901.838% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -19966.552% |
| BeyondSpring Inc. | 24.86 Million USD | -13117.756% |
| Synlogic, Inc. | 58.53 Million USD | -5515.04% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -18269.076% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -73065.516% |
| Peak Bio, Inc. | 1249.13 USD | -263110625.065% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -5337.242% |
| Krystal Biotech, Inc. | 160.42 Million USD | -1948.667% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -1114.419% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -844.321% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -152287.592% |
| MannKind Corporation | 125.59 Million USD | -2516.778% |
| Ikena Oncology, Inc. | 84.57 Million USD | -3785.921% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -33968.571% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -3568.034% |
| Gossamer Bio, Inc. | 183.75 Million USD | -1688.536% |
| CohBar, Inc. | 12.38 Million USD | -26429.837% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -6379.369% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -11815.724% |
| Legend Biotech Corporation | 583.14 Million USD | -463.598% |
| Mural Oncology plc | 192.07 Million USD | -1611.135% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -4794.627% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -20256.394% |
| Disc Medicine, Inc. | 91.12 Million USD | -3506.689% |
| Champions Oncology, Inc. | 28.11 Million USD | -11591.907% |
| REGENXBIO Inc. | 321.15 Million USD | -923.361% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -61202.957% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -5794.603% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -8335.68% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -2773.978% |
| Vaxart, Inc. | 90.72 Million USD | -3522.55% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -38475.022% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -7580.022% |
| Cellectis S.A. | 97.32 Million USD | -3277.101% |
| Longeveron Inc. | 21.25 Million USD | -15366.329% |
| Repare Therapeutics Inc. | 167.35 Million USD | -1863.823% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | -141.516% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -4244.762% |
| Revolution Medicines, Inc. | 498.76 Million USD | -558.947% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -49307.622% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -7377.351% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -4306.214% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -4619.746% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -29616.049% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 31.171% |
| Denali Therapeutics Inc. | 527.23 Million USD | -523.37% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -37866.069% |
| Veru Inc. | 101.34 Million USD | -3142.876% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -13941.077% |
| Cingulate Inc. | 22.75 Million USD | -14340.739% |
| Passage Bio, Inc. | 108.38 Million USD | -2932.222% |
| Context Therapeutics Inc. | 25.07 Million USD | -13008.305% |
| Exicure, Inc. | 14.07 Million USD | -23248.927% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -1494.939% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -7490.113% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -35712.26% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -1201.709% |
| Nuvalent, Inc. | 149.49 Million USD | -2098.509% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -40641.725% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -3070.859% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -15222.836% |
| OmniAb, Inc. | 83.89 Million USD | -3817.51% |
| Anew Medical, Inc. | 1.3 Million USD | -252551.554% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -9931.116% |
| Lipocine Inc. | 15.08 Million USD | -21694.196% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -4697.039% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -4215.835% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -8052.428% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -2761.816% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -14582.787% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -394.861% |
| Ocugen, Inc. | 71.56 Million USD | -4492.333% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -3401.369% |
| Q32 Bio Inc. | 92.68 Million USD | -3446.175% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -15421.843% |
| Alumis Inc. Common Stock | 158.17 Million USD | -1977.835% |
| Equillium, Inc. | 50.6 Million USD | -6394.477% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -5166.473% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -23535.123% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -17321.554% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -6900.053% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -2930.069% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -26420.353% |
| Dominari Holdings Inc. | 23.83 Million USD | -13688.945% |
| Edesa Biotech, Inc. | 9.22 Million USD | -35535.707% |
| vTv Therapeutics Inc. | 11.9 Million USD | -27502.209% |
| Bio-Techne Corporation | 563.03 Million USD | -483.724% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -703.95% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -1122.892% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -2384.631% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -22706.155% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -1907.743% |
| Nkarta, Inc. | 131.65 Million USD | -2396.464% |
| BioCardia, Inc. | 12.12 Million USD | -27014.883% |
| Iterum Therapeutics plc | 47.46 Million USD | -6823.812% |